Company Overview

Development Stage

About the Company

[Summary] 制药企业

南京海纳医药科技股份有限公司成立于2001年。公司管理层专业背景深厚,拥有优秀稳定的人才队伍,研发团队和管理团队年富力强,经验丰富。
公司是新药研发的科技型企业,拥有一流的自主研发团队和自主知识产权。从2010年至今,自主研发申报的品种50余项,已获得申报国家新药受理号100多个。获得发明专利13项。研发产品数量及审评通过率位居全国同行业前十。同时,我公司还被认定为“江苏省高新技术企业”、“江苏省民营科技企业”、“江苏省科技型中小型企业”。
新药研发是海纳医药的立足点与生命线,目前在南京设有三个研发中心,分别位于鼓楼、浦口和六合。共设立了12个研究平台,包含了新药研发的各项关键技术。
公司拥有两个控股子公司,分别为南京海纳制药有限公司和南京汇脉医疗科技有限公司,分别专注于自主研发新品的生产和医疗器械的经营销售。
海纳医药致力于建设成为集研发、生产、销售于一体的综合性医药企业,并为合作伙伴提供从药物发现、研究、注册、临床、原料药生产、中间体制造、制剂生产以及包装等新药开发全流程的服务及一体化的解决方案。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

海纳医药 Financing History (7 rounds)

Manage
并购
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 融资金额未公开
  • Investor: 成都先导

海纳医药 How Fast Is Hiring Growing? (64 open positions)

Manage
Note: How fast is hiring at 南京海纳医药科技股份有限公司 growing? 海纳医药2026: 129 openings (down 21%), 2025: 164 openings (up 20%), 2024: 137 openings (flat), 2023: 137 openings (up 117%), 2022: 63 openings (down 46%), 2021: 116 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

海纳医药 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 20%
  • 2024: Up 150%
  • 2023: Up 60%
  • 2022: Down 17%
海纳医药 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 南京海纳医药科技股份有限公司 growing? 海纳医药Master's recruitment over the years: 2025: 16 openings (down 20%), 2024: 20 openings (up 150%), 2023: 8 openings (up 60%), 2022: 5 openings (down 17%), 2021: 6 openings.

海纳医药 Doctoral Degree Job Demand Analysis

(More)
-80%
Growth Rate
2026 vs 2025
  • 2025: Up 67%
  • 2024: Flat 0%-
  • 2023: Up 50%
  • 2022: Flat 0%-
海纳医药 Doctoral Hiring by Year: 2026 — 4 fewer jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 南京海纳医药科技股份有限公司 growing? 海纳医药Doctorate recruitment over the years: 2026: 1 openings (down 80%), 2025: 5 openings (up 67%), 2024: 3 openings (flat), 2023: 3 openings (up 50%), 2022: 2 openings (flat), 2021: 2 openings.

海纳医药 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 南京海纳医药科技股份有限公司? Based on an analysis of 海纳医药's job postings over the past year, "生物/制药/化工/环保类" demand: 40.1%, "医疗卫生/美容保健类": 33.9%, "科研类": 7.9%, "其他(研发和技术类)": 7.3%, "机械/仪器仪表类": 7.3%, "电气/能源/动力类": 6.2%. For reference only.

海纳医药 — What Are the Salaries Like? (177 records)

Manage
salary range: 4.5K - 50K, 61% of roles pay ¥6-15K
Note: salary statistics are based on 177 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 南京海纳医药科技股份有限公司?海纳医药61% of positions earn 6-15K, Fresh graduate salary: ¥40.0K。生物/制药/化工/环保类 average salary ¥13.5K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 海纳医药

(More)
Are salaries high at 南京海纳医药科技股份有限公司? We provide: 分析,药品生产,组长,研究员,bd,车间,qc,主操,招商,副所长,工艺员,qa,班长,ma,临床,副主任,工艺技术,灌装,设备工,财务. Click to view detailed salary analysis by job.

海纳医药 — Fortune 500? (More)

海纳医药 honors, qualifications & industry associations

海纳医药 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 生物/制药/化工/环保类
    40.1% of total 40.1%
  • 经营管理类
    35.6% of total 35.6%
  • 医疗卫生/美容保健类
    33.9% of total 33.9%
  • 工厂生产类
    30.5% of total 30.5%

Education

  • 本科
    68.4% of total 68.4%
  • 大专
    19.8% of total 19.8%
  • 硕士
    10.2% of total 10.2%
  • 博士
    1.1% of total 1.1%

Experience

  • 5-10年
    37.3% of total 37.3%
  • 3-5年
    29.4% of total 29.4%
  • 不限
    22.6% of total 22.6%
  • 1-3年
    10.2% of total 10.2%
View Detailed Analysis

What does 南京海纳医药科技股份有限公司 require? Who is 海纳医药 hiring? 海纳医药 recruitment: 生物/制药/化工/环保类占比最多占40.1%,其次是经营管理类占35.6%. What education can get in at 海纳医药? 本科占比最多占68.4%,其次是大专占19.8%. High education required at 海纳医药? 硕士占10.2%,博士占1.1%. Work experience required at 海纳医药? 5-10年占比最多占37.3%,其次是3-5年占29.4%. Where are the job locations at 海纳医药? 南京占比最多占100%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 9,522.171万(元)
Legal Representative: 邹巧根
Date Established:
Credit Code: 91320100728341561X
Registered Address: 南京市鼓楼区新模范马路5号科技创新大楼A座15层

Partners & Suppliers

与公司签署战略合作协议,开展MAH合作,提供药品研发服务 Source
合作客户 研发合作
南京海纳医药为铭磊维生提供仿制药研发和技术服务 Source
合作客户 CRO/研发服务
与贝美药业合作开发儿童药物制剂 Source
合作客户 药品研发
华益药业为南京海纳医药提供口服固体制剂委托生产服务 Source
供应商 药物制剂委托生产(CMO/CDMO服务)
与南京医科大学附属医院开展临床试验合作 Source
供应商 技术联盟

People who follow 海纳医药 also follow

海纳医药 Competitors (Similar Companies)

“A high-tech pharmaceutical enterprise engaged in the full-industry-cha”
“Research, development, and production of anti-tumor and surgical medic”
“A renowned enterprise in China's liver disease and anti-tumor fields”
“以 “专业、专注、专心做好健康事业”为企业愿景”
“Health for Humanity, Creating a Better Future Together”
“To develop high-quality biologics that are accessible and affordable f”
制药/药业 中成药 医药 药物研发
“Innovative chemical products and services provider in the drug researc”
医药 药物研发 生物医药 试剂
“Supplier of pharmaceutical and cosmetic raw materials and fragrance ra”
医药 药物研发 仿制药 原料药
“An innovative company focused on R&D of medical device products”
医药 生物制品 医药中间体 生物科技/生物工程
制药/药业 细胞培养 医药 抗生素
制药/药业 医药 抗生素 原料药

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates